SCHEMBL5712947

SCHEMBL5712947

Nc1sc2c(c1C(=O)c1ccc(Cl)cc1)CCN(C(=O)Nc1ccccc1)C2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.62
KMT2A Q03164 5/20 0.62
TDP1 Q9NUW8 1/20 0.54
GAA P10253 2/20 0.50
ADORA1 P30542 4/20 0.49
MAPT P10636 3/20 0.49
KDM4E B2RXH2 1/20 0.49
TRPV1 Q8NER1 1/20 0.48
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5712958 0.90 ADORA1 (0.49) MEN1KMT2AGAAADORA1MAPT
SCHEMBL5712865 0.90 NPC1 (0.50) MEN1KMT2AGAAADORA1MAPT
SCHEMBL5506679 0.79 KMT2A (0.64) MEN1KMT2ATDP1GAAADORA1
SCHEMBL5342374 0.79 MAPT (0.63) MEN1KMT2ATDP1GAAADORA1
SCHEMBL5712840 0.78 ADORA1 (0.76) MEN1KMT2ATDP1ADORA1MAPT
SCHEMBL5506528 0.78 GAA (0.66) MEN1KMT2ATDP1GAAADORA1
SCHEMBL13738436 0.77 ADORA1 (0.58) MEN1KMT2AADORA1MAPTKDM4E
SCHEMBL5508041 0.74 MEN1 (0.62) MEN1KMT2ATDP1GAAADORA1
SCHEMBL6992778 0.73 ADORA1 (0.67) MEN1KMT2AADORA1MAPTKDM4E
SCHEMBL7685507 0.72 MEN1 (0.60) MEN1KMT2ATDP1ADORA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1671973-A2 Allosteric adenosine receptor modulators King Pharmaceuticals Research and Development, Inc. (US) 2006-06-21 EP claimed
EP-1671973-A2 Allosteric adenosine receptor modulators King Pharmaceuticals Research and Development, Inc. (US) 2006-06-21 EP disclosed
EP-1025106-B1 ALLOSTERIC ADENOSINE RECEPTOR MODULATORS KING PHARMACEUTICALS RES & DEV (US) 2006-06-21 EP disclosed
US-6323214-B1 CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS AND ANALGESICS MEDCO RESEARCH, INC 2001-11-27 US disclosed